GREY:TSTIF - Post by User
Post by
echo2on Dec 07, 2016 2:50pm
264 Views
Post# 25567560
Agreed. This is Sick.
Agreed. This is Sick.Company comes out with a PR a few days ago that is fundamentally very positive confirming Getinge's base commitment into 2017 and >18 M US in backlog. And, the share price sells off a couple of days later? Like this?
Admittedly, The Donald came out with another stupid tweet about controlling drug prices in the US causing a healthcare sell-off, but TSO3 is a technology company that makes the new standard of care for low temperature sterilization. This is not remotely a drug company. The Donald should be saying how he thinks the FDA should fast-track any data from TSO3 for further extended claims to include duodenoscopes in addition to the colonoscopes that only the VP4 can sterilize! When The Donald has his next appointment for a colonoscopy will he demand that the instrument used be sterile? I hope so and so should all patients!
And, management must be more than frustrated that they have to spend another day on the phone fielding calls from NB, Dejardins, Canaccord, and others to explain and reiterate that there is no negative news coming regarding TSO3. And, the shorts are laughing at the distraction they created.
Perhaps, the company should announce a share buy-back at these ludicrous levels. They have the cash to easily buy-back a few million TOS shares!
Recap of positive news coming:
- EU roll-out and Pass-through units approved in EU
- New further scientific validation studies in peer reviewed journals
- Further development of the smaller 80L system
- Strategic installations and positive user experiences, including reiteration of Getinge's unwavering highlighting of this star product line
- completion of FDA data collection and submission in support of extending sterilzation claims further to include duodenoscopes
Again, I am sure management is extremely upset about these unjustified repeated set-backs in the share price. The fundamentals are extremely positive and strong. Managements plate is full of great things. And, I am sure they are concerned that if TSO3 was a take-out target at 3.60+, they are a screaming steal at anything approaching the share price today or even at 3.60!!.
Personally, I continue to add to my holdings.